Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: Could metformin help?
- 1 January 2014
- journal article
- review article
- Published by Elsevier in Gynecologic Oncology
- Vol. 132 (1) , 248-253
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Progesterone Resistance in PCOS Endometrium: A Microarray Analysis in Clomiphene Citrate-Treated and Artificial Menstrual CyclesThe Journal of Clinical Endocrinology & Metabolism, 2011
- Understanding the benefit of metformin use in cancer treatmentBMC Medicine, 2011
- Effects of metformin and leuprolide acetate on insulin resistance and testosterone levels in nondiabetic postmenopausal women: a randomized, placebo-controlled trialFertility and Sterility, 2010
- Metabolic syndrome and endometrial cancer riskAnnals of Oncology, 2010
- Complex Hyperplasia With and Without AtypiaObstetrics & Gynecology, 2010
- Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndromeGynecologic Oncology, 2009
- Incidence of endometrial hyperplasiaAmerican Journal of Obstetrics and Gynecology, 2009
- Effect of Testosterone on Insulin Stimulated IRS1 Ser Phosphorylation in Primary Rat Myotubes—A Potential Model for PCOS-Related Insulin ResistancePLOS ONE, 2009
- A Prospective Evaluation of Insulin and Insulin-like Growth Factor-I as Risk Factors for Endometrial CancerCancer Epidemiology, Biomarkers & Prevention, 2008
- Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health planBritish Journal of Cancer, 2007